Projects funded by the NCN

The active center and beyond: towards new selective inhibitors of S-adenosyl-L-homocysteine hydrolase. Structural enzymo...

Call: OPUS 5 , Panel: NZ1

Principal investigator: dr Krzysztof Brzeziński

Uniwersytet w Białymstoku, Wydział Biologiczno-Chemiczny

Design and synthesis of selective and irreversible inhibitors of HAT protease.

Call: PRELUDIUM 5 , Panel: ST5

Principal investigator: Marcin Skoreński

Politechnika Wrocławska, Wydział Chemiczny

Impact of combined therapy of non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors on oxida...

Call: OPUS 3 , Panel: NZ5

Principal investigator: dr hab. Piotr Gałecki

Uniwersytet Medyczny w Łodzi, Wydział Wojskowo-Lekarski; Klinika Psychiatrii Dorosłych

Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from mole...

Call: SONATA 19 , Panel: NZ7

Principal investigator: dr Artur Świerczek

Uniwersytet Jagielloński, Collegium Medicum

Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

Call: OPUS 25 , Panel: NZ7

Principal investigator: dr Natalia Eleonora Małek-Chudzik

Politechnika Wrocławska

SELECTIVE REGULATION OF RAB GTPASES BY TARGETING PROTEIN-PROTEIN INTERACTIONS BETWEEN RABS AND REGULATORY PROTEINS

Call: PRELUDIUM BIS 3 , Panel: ST4

Principal investigator: dr hab. Katarzyna Magdalena Błażewska

Politechnika Łódzka, Wydział Chemiczny

Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of ...

Call: OPUS 21 , Panel: NZ7

Principal investigator: prof. Piotr Wiktor Wlaź

Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

Call: OPUS 21 , Panel: NZ7

Principal investigator: dr Dawid Marcin Panek

Uniwersytet Jagielloński, Collegium Medicum

Design of high selective and safe juvenile hormone epoxide hydrolases inhibitors targeting selected pests based on the c...

Call: OPUS 20 , Panel: ST4

Principal investigator: dr hab. Artur Wiktor Góra

Politechnika Śląska, Centrum Biotechnologii

The use of evolutionary patterns in the optimization of chemotherapy of tuberculosis

Call: SONATA BIS 9 , Panel: NZ6

Principal investigator: dr Alina Ewa Minias

Instytut Biologii Medycznej Polskiej Akademii Nauk

Effect of therapy with selective serotonin reuptake inhibitors and physical exercise on blood brain barrier permeability...

Call: PRELUDIUM 17 , Panel: NZ5

Principal investigator: Marta Anna Małkiewicz

Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth...

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Godefridus J Peters

Gdański Uniwersytet Medyczny, Wydział Lekarski

Organometallic compounds as selective inhibitors of selected multidrug resistance proteins

Call: OPUS 15 , Panel: ST5

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki, Wydział Chemii

The influence of perinatal exposure to selective serotonin reuptake inhibitors on the structure and functions of mice do...

Call: OPUS 14 , Panel: NZ4

Principal investigator: prof. Grzegorz Władysław Hess

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

3D structure-based search for selective inhibitor of thymidylate synthase of nematodes, a potential drug in chemotherapy...

Call: OPUS 1 , Panel: NZ6

Principal investigator: prof. Wojciech Krzysztof Rode

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk